Stockreport

NantHealth and NantOmics Announce Publication of Study Highlighting High Error Rates in Tumor-Only Sequencing for Cancer Treatment

NantHealth, Inc.  (NH) 
Last nanthealth, inc. earnings: 11/7 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: nanthealth.com
PDF Research shows approach that includes sequencing both normal genomes and tumor genomes increases accuracy and precision CULVER CITY, Calif.--(BUSIN [Read more]